Tag: medicine

By [email protected]_84

Summit, Colorado Center for Personalized Medicine to Develop Saliva Tests for COVID, Head & Neck Cancer

AURORA, Colo., Oct. 14, 2020 /PRNewswire/ — Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.

The CCPM holds one of the largest research biobanks in the United States with clinical data from more than 8.7 million de-identified patient records and plans to integrate the data with personalized genomic information.

“This partnership brings two innovative programs together to optimize COVID testing at a time when it’s desperately needed,” says Kathleen Barnes, Ph.D., Professor and Director of CCPM at the University of Colorado Anschutz Medical Campus. “Collaborations like this are crucial in moving research forward and

Read More
By [email protected]_84

Summa Equity Acquires Sengenics to Advance Precision Medicine Through Proteomics

Summa Equity, the purpose-driven private equity firm that invests to solve global challenges, has acquired a majority stake in Sengenics, a functional proteomics company with a proprietary technology called KREX that enables researchers to vastly improve the understanding of the human proteome and immune system. Proteomics, i.e. the large-scale study of proteins, is one of the most important areas for gaining insights into human biology and disease, as protein expressions, structures and functions are critical in reflecting states of health.

Sengenics was first founded in 2008 and went on to commercialise the KREX technology that was originally developed from a joint collaboration between the University of Cambridge and the University of Oxford. The company’s patented KREX technology enables researchers to address both the function and folding structure of proteins using one technology that allows for large numbers of proteins to be studied simultaneously, with high sensitivity and specificity. The combination

Read More
By [email protected]_84

Lipocine Announces Presentations at the 21st Annual Fall Meeting of the Sexual Medicine Society of North America

SALT LAKE CITY, Oct. 14, 2020 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced it will present results from studies suggesting that low testosterone levels may play an important role on the clinical outcomes of COVID-19 in men as well as the safety and efficacy of TLANDO™, an oral testosterone replacement therapy without a dose titration requirement, at the 21st Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (“SMSNA”). Lipocine will outline the possible mechanisms and clinical evidence that suggests men with low testosterone have poor COVID-19 outcomes, and the rationale of using an oral testosterone therapy for men with COVID-19. Results from the previously completed dose validation (“DV”) study of a fixed dose TLANDO in hypogonadal males will also be presented at the meeting.  The presentations will take place virtually on November 9, 2020

Read More
By [email protected]_84

Launch a Global Medical Career with Manipal’s American University of Antigua, College of Medicine

Medical students can be an efficient contingency workforce, provided their lack of training is suitably addressed. Being capable and ready to respond to COVID-19 like pandemic situation needs crucial emphasis on disaster management and emergency medicine. The world is faced with the reality of the shortage of physicians and healthcare providers due to the challenges posed by the current epidemiological peak. From the larger perspective, it is about how the shortage of physicians worldwide is going to impact the global health scenario. A lack of training renders medical students non-essential to patient care; on the other hand, clinical training is essential to generate future responders against COVID-19. What should be the focus of medical institutions and aspiring medical students?

Manipal’s American University of Antigua College of Medicine (AUA) is one such renowned institute in the Caribbean that helps students from different corners of the world to fulfill their dreams of

Read More
By [email protected]_84

Living Health Integrative Medicine Celebrates its 19th Anniversary

Living Health Integrative Medicine, Which Was Founded by Dr. Thomas Chaney and Dr. Stephanie Chaney, Provides a Natural and Effective Integrative Approach to Health

ANNAPOLIS, MD / ACCESSWIRE / October 13, 2020 / Dr. Thomas Chaney and Dr. Stephanie Chaney are pleased to announce that Living Health Integrative Medicine, which they co-founded, is celebrating 19 years in business.

To contact Living Health Integrative Medicine and/or to sign up for their newsletter, please visit https://www.mylivinghealth.com/contact-us/.

As Dr. Thomas Chaney noted, he and Dr. Stephanie Chaney are proud of the way their devotion to integrative medicine has helped Living Health Integrative Medicine to become the leader in holistic wellness throughout Maryland, Washington DC and Northern Virginia.

They also take pride in the fact that they are leaders in functional medicine and physical medicine. They use the most current research and science to help guide the treatments they suggest for their valued patients.

Read More
By [email protected]_84

Executive Medicine of Texas puts the Spotlight on Alzheimer’s Disease

Deaths from Alzheimer’s disease are increasing exponentially, but gaining little attention from the general public due to the Covid19 pandemic and other issues. Executive Medicine of Texas is working diligently to change the narrative and place focus on education and prevention of this terrible disease. Their first move, is hosting the first Alzheimer’s and the Arts Event, which will showcase the film “Have You Heard about Greg?”

DALLAS (PRWEB) October 13, 2020

According to the Alzheimer’s Association, since the year 2000, deaths from Alzheimer’s have increased by 146%. This is while deaths from heart disease have decreased by 7.8%. Alzheimer’s Disease is the sixth leading cause of death in the US, claiming more lives than breast cancer and prostate cancer combined.

“Our patients are concerned about their brain health and so are we,” says Mark Anderson, MD and one of the founders of Executive Medicine of Texas. “Years ago we

Read More
By [email protected]_84

Disc Medicine Expands Scientific Advisory Board with Leading Experts in Hepcidin Biology

CAMBRIDGE, Mass., Oct. 13, 2020 /PRNewswire/ — Disc Medicine, a company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced the appointment of Tomas Ganz, MD, PhD and Elizabeta Nemeth, PhD to its scientific advisory board, adding valuable expertise in hepcidin biology.

“We are thrilled to welcome  Dr. Ganz and Dr. Nemeth to our Scientific Advisory Board, particularly at such an exciting time in a field that they helped pioneer,” said John Quisel, JD, PhD, Chief Executive Officer at Disc Medicine. “Together they were instrumental in characterizing the fundamental role of hepcidin in iron homeostasis, and I’m delighted to be working with them as we advance our hepcidin-targeted programs into the clinic.”

Dr. Ganz is a Distinguished Professor of Medicine and Pathology at the David Geffen School of Medicine at UCLA, where he studies the role

Read More
By [email protected]_84

3D metal printer at College of Dental Medicine expands possibilities for innovation

IMAGE

IMAGE: The component that Renne was able to print for the ZIAN team.
view more 

Credit: MUSC

When the Zucker Institute for Applied Neurosciences at the Medical University of South Carolina needed to bring to life a neurosurgeon’s idea for better instrumentation for sacroiliac surgery, there was one obvious partner to turn to: the MUSC College of Dental Medicine.

The college is the only dental program in the nation to have the Sisma Mysint100 3D selective laser fusion printer that creates 3D prints from metal rather than plastic, and Walter Renne, D.M.D., a professor in the Department of Oral Rehabilitation and assistant dean of innovation and digital dentistry, is eager to see what it can do.

“3D printing is how we get stuff from our imagination into reality. One of the issues in the past was most of what we could print was plastic, and plastic degrades. You need something

Read More
By [email protected]_84

SEngine Precision Medicine to Present at Society of Functional Precision Medicine Virtual …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

SEATTLE, Oct. 13, 2020 (GLOBE NEWSWIRE) — SEnginePrecision Medicine, a precision oncology company revolutionizing cancer diagnostics and drug discovery by pre-testing drugs on patient-derived tumor organoids, today announced that Chief Medical Officer Astrid L. Margossian, MD, PhD, will present at the Society for Functional Precision Medicine (SFPM) Virtual Monthly Seminar on October 14th at 11:30 am ET.

Dr. Margossian is leading SEngine’s clinical validation initiatives for the PARIS® Test, a CLIA certified cancer organoid based drug sensitivity test for all solid tumors. The presentation is entitled, “Predictive Clinical Value of a CLIA-Approved Organoid Based Drug Sensitivity Test,” and will highlight the data on the PARIS® Test, recently presented at the ASCO 2020 and ACCR 2020 annual meetings, inclusive of organoids sensitivity results, showing clinical correlation with genomics and previous

Read More
By [email protected]_84

Disc Medicine Expands Scientific Advisory Board with Leading Experts in Hepcidin Biology | Nachricht

CAMBRIDGE, Mass., Oct. 13, 2020 /PRNewswire/ — Disc Medicine, a company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced the appointment of Tomas Ganz, MD, PhD and Elizabeta Nemeth, PhD to its scientific advisory board, adding valuable expertise in hepcidin biology.

Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic diseases. (PRNewsfoto/Disc Medicine)

“We are thrilled to welcome Dr. Ganz and Dr. Nemeth to our Scientific Advisory Board, particularly at such an exciting time in a field that they helped pioneer,” said John Quisel, JD, PhD, Chief Executive Officer at Disc Medicine. “Together they were instrumental in characterizing the fundamental role of hepcidin in iron homeostasis, and I’m delighted to be working with them as we advance our hepcidin-targeted programs into the clinic.”

Dr. Ganz is a Distinguished Professor of Medicine and Pathology at the David Geffen School of Medicine at UCLA, where he studies the role

Read More